Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the effects of rapamycin directly on bladder tumors and the
effects of rapamycin on the immune system of patients with bladder cancer.
Phase:
Early Phase 1
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio